Key result
Cardiopulmonary bypass during CABG is linked to elevated renal biomarker excretion lasting up to 40 days.
Why the study?
A variable incidence rate of renal dysfunction after cardiac surgery with cardiopulmonary bypass has been reported, prompting the need to define the typical pattern of renal dysfunction following coronary surgery using specific excretion indicators.
Observational (n=20)
Myocardial revascularization with cardiopulmonary bypass induces temporary glomerular and tubular renal dysfunction that can persist for up to 40 days postoperatively.
Answers are grounded in this paper and cite their sources.
May warrant extended renal monitoring after bypass; leaves open prognostic value of these markers.
Background and objective: A variable incidence rate of renal dysfunction (3–35%) after cardiac surgery with cardiopulmonary bypass has been reported. The aim was to define the typical pattern of renal dysfunction that follows coronary surgery with cardiopulmonary bypass using albumin, immunoglobulin (IgG), α1-microglobulin and β-glucosaminidase (β-NAG) excretion as indicators. Methods: Twenty patients with preoperative normal renal function, defined by plasma creatinine, creatinine clearance, fractional excretion of sodium and renal excretion of proteins, undergoing elective myocardial revascularization surgery with cardiopulmonary bypass, were prospectively studied. Variables recorded were demographic and haemodynamic variables, duration of cardiopulmonary bypass and aortic clamping, intra- and postoperative urine output, plasma creatinine concentration, creatinine clearance and excretion of sodium, albumin, IgG, β-glucosaminidase (β-NAG), and α1-microglobulin. Measurements were made preoperatively, immediately before and then during and immediately after cardiopulmonary bypass, and again at 1, 24, 72 h, 7 and 40 days following surgery. Results: Albumin and IgG excretion rose significantly during cardiopulmonary bypass (P < 0.05), remaining at these levels at 24 h postoperatively. An increase of α1-microglobulin and β-NAG concentrations was observed during cardiopulmonary bypass (P < 0.05), which were maintained until the seventh postoperative day and remained elevated in some patients at the 40th postoperative day. This correlated with preoperative diabetes mellitus (P < 0.001), low cardiac output after cardiopulmonary bypass (P < 0.001) and the duration of stay in the intensive care unit (P < 0.001). Conclusions: The pattern of renal dysfunction after cardiopulmonary bypass for myocardial revascularization is characterized by temporary renal dysfunction at both glomerular and tubular levels with an onset within 24 h of surgery and which lasts between 24 h and 40 days, respectively, following surgery.
No takes yet. Share an insight, caveat, or question.
Faulí et al. (2003) conducted an observational in Myocardial revascularization surgery with cardiopulmonary bypass (n=20). Cardiopulmonary bypass during myocardial revascularization surgery vs. Preoperative baseline was evaluated on Renal excretion of albumin, IgG, α1-microglobulin and β-NAG (p=<0.05). Cardiopulmonary bypass during myocardial revascularization surgery was associated with significant increases in albumin, IgG, α1-microglobulin, and β-NAG excretion (P<0.05), lasting up to 40 days.
Synapse has enriched 10 related papers. Consider them for comparative context: